This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
VNUS Medical Technologies, Inc.
VNUS Medical Technologies, Inc., a prominent player in the medical device industry, is headquartered in the United States. Founded in the early 2000s, the company has established itself as a leader in innovative solutions for the treatment of venous diseases, particularly through its advanced endovenous laser therapy (EVLT) systems. With a focus on minimally invasive procedures, VNUS offers unique products that enhance patient outcomes and streamline clinical workflows. The company has achieved significant milestones, including the development of proprietary technologies that set it apart in the competitive landscape. Recognised for its commitment to quality and innovation, VNUS Medical Technologies continues to expand its operational reach, serving healthcare professionals across major regions in the US and beyond. Its dedication to advancing venous health solutions solidifies its position as a trusted name in the industry.
DitchCarbon Score
How does VNUS Medical Technologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
VNUS Medical Technologies, Inc.'s score of 48 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
VNUS Medical Technologies, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Medtronic plc, and as such, it inherits emissions data and climate commitments from its parent organisation. As part of its climate strategy, VNUS Medical Technologies aligns with the sustainability initiatives set forth by Medtronic plc. This includes participation in various climate-related frameworks such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are cascaded from Medtronic. However, specific reduction targets or achievements for VNUS Medical Technologies have not been disclosed. While no absolute emissions figures are provided, VNUS Medical Technologies is committed to addressing climate change through the broader goals established by Medtronic plc, which may include significant reductions in greenhouse gas emissions across their operations. The company is expected to contribute to these initiatives as part of its corporate responsibility and sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
VNUS Medical Technologies, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
